Carmofur
Carmofur (HCFU) is a potent acid ceramidase inhibitor investigated for breast and colorectal cancer. Research applications include in vitro studies of ceramide metabolism and in vivo models exploring its antitumor effects and associated leukoencephalopathy.
Product Specifications
CAS Number
61422-45-5
Product Name Alternative
Derivative, DNA/RNA Synthesis, DNA Synthesis, DNASynthesis, Analog, antineoplastic, Carmofur, 5-fluorouracil, inhibit, Mpro, Nucleoside Antimetabolite/Analog, NucleosideAntimetabolite, Nucleoside Antimetabolite, HCFU, Inhibitor, VirusProtease, Virus Protease, protease, RNASynthesis, RNA Synthesis, SARSCoV, SARS-CoV, SARS coronavirus
Field of Research
Cell Biology, Infectious Disease & Virology, Metabolism Research, Molecular Biology, Neuroscience, Pharmacology & Drug Discovery
Purity
98.53% (May vary between batches)
Solubility
DMSO:250 mg/mL (971.78 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:10 mg/mL (38.87 mM)
Smiles
CCCCCCNC (=O) n1cc (F) c (=O) [nH]c1=O
Molecular Formula
C11H16FN3O3
Molecular Weight
257.26
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1140355-01 0.02 mg (E-Coli)
Recombinant Mycobacterium bovis Pyridoxal biosynthesis lyase pdxS (pdxS)
Sign In for Pricing
View Details MBS1140355-02 0.02 mg (Yeast)
Recombinant Mycobacterium bovis Pyridoxal biosynthesis lyase pdxS (pdxS)
Sign In for Pricing
View Details MBS1140355-03 0.1 mg (E-Coli)
Recombinant Mycobacterium bovis Pyridoxal biosynthesis lyase pdxS (pdxS)
Sign In for Pricing
View Details